Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Michael S Hearne. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Michael S Hearne har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:LJPC / La Jolla Pharmaceutical Co. | Chief Financial Officer | 0 |
US:ODT / Odonate Therapeutics Inc | Chief Financial Officer | 12 767 435 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Michael S Hearne. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ODTC / Odonate, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ODTC / Odonate, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ODTC / Odonate, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Michael S Hearne som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-08-24 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
U - Other | −9 607 934 | 0 | −100,00 | 6,23 | −59 857 429 | ||
2022-08-24 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
U - Other | −9 607 934 | 0 | −100,00 | 6,23 | −59 857 429 | ||
2022-08-24 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
D - Sale to Issuer | −10 186 | 0 | −100,00 | 6,23 | −63 459 | ||
2022-07-05 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 236 | 10 186 | 2,37 | 2,71 | 640 | 27 619 | |
2022-06-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 236 | 9 950 | 2,43 | 2,72 | 642 | 27 064 | |
2022-06-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 189 | 9 714 | 1,98 | 3,41 | 644 | 33 110 | |
2022-05-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 188 | 188 | |||||
2022-05-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 188 | 9 525 | 2,01 | 3,41 | 641 | 32 466 | |
2022-05-03 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 185 | 185 | |||||
2022-05-03 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 185 | 9 337 | 2,02 | 3,47 | 642 | 32 381 | |
2022-04-18 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 173 | 173 | |||||
2022-04-18 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 173 | 9 152 | 1,93 | 3,71 | 643 | 33 995 | |
2022-04-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 177 | 177 | |||||
2022-04-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 177 | 8 979 | 2,01 | 3,63 | 642 | 32 589 | |
2022-03-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 190 | 190 | |||||
2022-03-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 190 | 8 802 | 2,21 | 3,37 | 640 | 29 628 | |
2022-03-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 185 | 185 | |||||
2022-03-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 185 | 8 612 | 2,20 | 3,48 | 643 | 29 940 | |
2022-02-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 169 | 169 | |||||
2022-02-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 169 | 8 427 | 2,05 | 3,79 | 641 | 31 947 | |
2022-02-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 1 675 | 1 675 | |||||
2022-02-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 1 675 | 8 258 | 25,44 | 3,94 | 6 592 | 32 499 | |
2022-01-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 148 | 148 | |||||
2022-01-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 148 | 6 583 | 2,30 | 4,18 | 619 | 27 530 | |
2022-01-14 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 78 552 | 78 552 | |||||
2022-01-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 157 | 157 | |||||
2022-01-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 157 | 6 435 | 2,50 | 3,92 | 615 | 25 216 | |
2021-12-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 173 | 173 | |||||
2021-12-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 173 | 6 278 | 2,83 | 3,58 | 619 | 22 466 | |
2021-12-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 186 | 186 | |||||
2021-12-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 186 | 6 105 | 3,14 | 3,32 | 617 | 20 238 | |
2021-12-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
S - Sale | −41 290 | 9 607 934 | −0,43 | 3,66 | −151 303 | 35 207 313 | |
2021-12-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
S - Sale | −136 255 | 9 649 224 | −1,39 | 3,76 | −512 128 | 36 267 573 | |
2021-12-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
S - Sale | −63 745 | 9 785 479 | −0,65 | 3,95 | −251 544 | 38 614 479 | |
2021-12-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
S - Sale | −6 597 | 9 849 224 | −0,07 | 3,95 | −26 067 | 38 918 224 | |
2021-12-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
S - Sale | −193 403 | 9 855 821 | −1,92 | 4,10 | −793 107 | 40 416 751 | |
2021-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
S - Sale | −365 289 | 12 767 435 | −2,78 | 1,92 | −699 930 | 24 463 682 | |
2021-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
S - Sale | −381 842 | 13 132 724 | −2,83 | 1,89 | −722 636 | 24 853 680 | |
2021-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
S - Sale | −500 000 | 13 514 566 | −3,57 | 1,88 | −940 600 | 25 423 602 | |
2021-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
S - Sale | −212 423 | 14 014 566 | −1,49 | 1,97 | −418 643 | 27 619 907 | |
2021-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
S - Sale | −287 577 | 14 226 989 | −1,98 | 2,20 | −632 238 | 31 278 035 | |
2021-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
S - Sale | −500 000 | 14 514 566 | −3,33 | 2,02 | −1 008 050 | 29 262 817 | |
2021-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
S - Sale | −31 151 | 15 014 566 | −0,21 | 1,99 | −62 118 | 29 940 546 | |
2021-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
S - Sale | −468 849 | 15 045 717 | −3,02 | 2,66 | −1 246 341 | 39 996 030 | |
2021-11-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 181 | 181 | |||||
2021-11-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 181 | 5 919 | 3,15 | 3,41 | 617 | 20 175 | |
2021-11-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 181 | 181 | |||||
2021-11-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 181 | 5 738 | 3,26 | 3,42 | 618 | 19 607 | |
2021-10-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 183 | 183 | |||||
2021-10-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 183 | 5 557 | 3,41 | 3,37 | 616 | 18 705 | |
2021-10-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 182 | 182 | |||||
2021-10-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 182 | 5 374 | 3,51 | 3,39 | 617 | 18 226 | |
2021-09-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 546 | 546 | |||||
2021-09-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 546 | 5 192 | 11,75 | 3,39 | 1 852 | 17 609 | |
2021-08-03 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 201 | 201 | |||||
2021-08-03 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 201 | 4 646 | 4,52 | 3,07 | 617 | 14 256 | |
2021-07-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 193 | 193 | |||||
2021-07-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 193 | 4 445 | 4,54 | 3,20 | 617 | 14 206 | |
2021-07-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 170 | 170 | |||||
2021-07-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 170 | 4 252 | 4,16 | 3,64 | 618 | 15 469 | |
2021-06-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 148 | 148 | |||||
2021-06-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 148 | 4 082 | 3,76 | 4,16 | 616 | 17 002 | |
2021-06-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 169 | 169 | |||||
2021-06-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 169 | 3 934 | 4,49 | 3,66 | 618 | 14 379 | |
2021-06-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 43 734 | 10 049 224 | 0,44 | 4,53 | 198 014 | 45 499 872 | |
2021-06-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 15 358 | 10 005 490 | 0,15 | 4,29 | 65 917 | 42 943 563 | |
2021-06-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 184 642 | 9 990 132 | 1,88 | 4,47 | 825 978 | 44 689 856 | |
2021-06-01 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 1 286 | 9 805 490 | 0,01 | 4,50 | 5 785 | 44 109 016 | |
2021-05-26 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 166 932 | 9 804 204 | 1,73 | 4,26 | 710 763 | 41 744 340 | |
2021-05-26 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 31 782 | 9 637 272 | 0,33 | 3,83 | 121 874 | 36 956 047 | |
2021-05-26 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 95 597 | 9 605 490 | 1,01 | 3,77 | 360 860 | 36 258 804 | |
2021-05-26 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 104 403 | 9 509 893 | 1,11 | 3,68 | 384 234 | 34 999 259 | |
2021-05-18 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 193 | 193 | |||||
2021-05-18 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 193 | 3 765 | 5,40 | 3,20 | 617 | 12 033 | |
2021-05-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 163 | 163 | |||||
2021-05-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 163 | 3 572 | 4,78 | 3,77 | 615 | 13 481 | |
2021-04-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 173 | 173 | |||||
2021-04-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 173 | 3 835 | 4,72 | 3,55 | 615 | 13 626 | |
2021-04-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 172 | 172 | |||||
2021-04-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 172 | 3 662 | 4,93 | 3,60 | 620 | 13 198 | |
2021-03-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 37 | 37 | |||||
2021-03-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 37 | 2 620 | 1,43 | 16,22 | 600 | 42 496 | |
2021-03-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 127 | 127 | |||||
2021-03-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 127 | 3 490 | 3,78 | 4,85 | 616 | 16 939 | |
2021-03-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 34 | 34 | |||||
2021-03-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 34 | 2 583 | 1,33 | 17,89 | 608 | 46 210 | |
2021-03-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 139 | 139 | |||||
2021-03-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 139 | 3 363 | 4,31 | 4,45 | 619 | 14 979 | |
2021-02-18 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 535 | 535 | |||||
2021-02-18 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 535 | 3 224 | 19,90 | 5,70 | 3 051 | 18 388 | |
2021-02-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 28 | 28 | |||||
2021-02-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 28 | 2 549 | 1,11 | 21,19 | 593 | 54 013 | |
2021-02-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 31 | 31 | |||||
2021-02-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 31 | 2 521 | 1,24 | 19,64 | 609 | 49 512 | |
2021-02-02 |
|
4/A | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 1 648 | 2 435 | 209,40 | 3,30 | 5 435 | 8 031 | |
2021-02-02 |
|
4/A | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 136 | 2 571 | 5,59 | 4,55 | 618 | 11 692 | |
2021-02-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 118 | 118 | |||||
2021-02-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 118 | 2 689 | 4,59 | 5,20 | 614 | 13 988 | |
2021-01-20 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 35 | 35 | |||||
2021-01-20 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 35 | 2 490 | 1,43 | 16,99 | 595 | 42 305 | |
2021-01-20 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 136 | 136 | |||||
2021-01-20 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 136 | 1 094 | 14,20 | 4,55 | 618 | 4 975 | |
2021-01-05 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 350 | 350 | |||||
2021-01-05 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 350 | 2 455 | 16,63 | 16,32 | 5 712 | 40 066 | |
2021-01-05 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 171 | 171 | |||||
2021-01-05 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 171 | 958 | 21,73 | 3,30 | 564 | 3 159 | |
2020-12-23 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 75 784 | 15 514 566 | 0,49 | 15,71 | 1 190 415 | 243 702 803 | |
2020-12-23 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 63 354 | 15 438 782 | 0,41 | 15,43 | 977 438 | 238 192 616 | |
2020-12-23 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 36 646 | 15 375 428 | 0,24 | 15,17 | 555 821 | 233 203 729 | |
2020-12-23 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 37 856 | 15 338 782 | 0,25 | 14,58 | 551 766 | 223 568 883 | |
2020-12-23 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 62 144 | 15 300 926 | 0,41 | 14,58 | 905 767 | 223 015 587 | |
2020-12-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 43 | 43 | |||||
2020-12-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 43 | 2 105 | 2,09 | 12,91 | 555 | 27 176 | |
2020-12-16 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 147 | 147 | |||||
2020-12-16 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 147 | 787 | 22,97 | 3,82 | 562 | 3 010 | |
2020-12-14 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 52 191 | 52 191 | |||||
2020-12-10 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 22 639 | 22 639 | |||||
2020-12-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 45 | 45 | |||||
2020-12-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 45 | 2 062 | 2,23 | 12,77 | 575 | 26 332 | |
2020-12-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 134 | 134 | |||||
2020-12-02 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 134 | 640 | 26,48 | 4,22 | 566 | 2 704 | |
2020-11-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 141 | 141 | |||||
2020-11-17 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 141 | 506 | 38,63 | 3,98 | 561 | 2 013 | |
2020-11-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 46 | 46 | |||||
2020-11-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 46 | 2 017 | 2,33 | 12,20 | 561 | 24 607 | |
2020-11-05 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 196 | 196 | |||||
2020-11-05 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 196 | 365 | 115,98 | 2,89 | 566 | 1 055 | |
2020-11-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 46 | 46 | |||||
2020-11-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 46 | 1 971 | 2,39 | 12,25 | 564 | 24 145 | |
2020-10-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 42 | 42 | |||||
2020-10-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 42 | 1 925 | 2,23 | 13,35 | 561 | 25 699 | |
2020-10-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy) |
A - Award | 169 | 169 | |||||
2020-10-19 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
A - Award | 169 | 169 | 3,32 | 561 | 561 | ||
2020-10-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 50 | 50 | |||||
2020-10-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 50 | 1 883 | 2,73 | 11,42 | 571 | 21 504 | |
2020-09-30 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 882 | 15 238 782 | 0,07 | 13,85 | 150 698 | 211 032 749 | |
2020-09-30 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 100 000 | 15 227 900 | 0,66 | 13,06 | 1 305 710 | 198 832 213 | |
2020-09-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 43 | 43 | |||||
2020-09-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 43 | 1 833 | 2,40 | 13,06 | 562 | 23 939 | |
2020-09-09 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 78 369 | 9 405 490 | 0,84 | 4,03 | 316 047 | 37 930 460 | |
2020-09-09 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 48 296 | 9 327 121 | 0,52 | 4,01 | 193 894 | 37 445 593 | |
2020-09-09 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 84 152 | 9 278 825 | 0,92 | 3,90 | 328 529 | 36 224 533 | |
2020-09-09 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 67 552 | 9 194 673 | 0,74 | 3,82 | 258 359 | 35 165 946 | |
2020-09-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 42 | 42 | |||||
2020-09-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 42 | 1 790 | 2,40 | 13,73 | 577 | 24 577 | |
2020-09-01 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 1 052 631 | 15 127 900 | 7,48 | 14,25 | 14 999 992 | 215 572 575 | |
2020-08-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 18 | 18 | |||||
2020-08-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 18 | 1 748 | 1,04 | 30,71 | 553 | 53 681 | |
2020-08-14 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 168 669 | 9 127 121 | 1,88 | 3,88 | 653 694 | 35 373 070 | |
2020-08-14 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 219 465 | 8 958 452 | 2,51 | 3,65 | 800 586 | 32 679 537 | |
2020-08-14 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 43 513 | 8 738 987 | 0,50 | 3,47 | 150 820 | 30 290 203 | |
2020-08-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 18 | 18 | |||||
2020-08-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 18 | 1 730 | 1,05 | 30,91 | 556 | 53 474 | |
2020-07-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 17 | 17 | |||||
2020-07-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 17 | 1 712 | 1,00 | 34,99 | 595 | 59 903 | |
2020-07-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 15 | 15 | |||||
2020-07-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 15 | 1 695 | 0,89 | 35,99 | 540 | 61 003 | |
2020-06-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 17 | 17 | |||||
2020-06-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 17 | 1 680 | 1,02 | 34,21 | 582 | 57 473 | |
2020-06-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 215 812 | 8 695 474 | 2,55 | 4,94 | 1 065 636 | 42 936 512 | |
2020-06-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 145 764 | 8 479 662 | 1,75 | 4,90 | 714 783 | 41 581 719 | |
2020-06-04 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Common Stock |
P - Purchase | 253 553 | 8 333 898 | 3,14 | 4,88 | 1 237 060 | 40 660 255 | |
2020-06-03 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
2020-06-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 40 | 40 | |||||
2020-06-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 40 | 1 663 | 2,46 | 27,77 | 1 111 | 46 182 | |
2020-05-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 47 | 47 | |||||
2020-05-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 47 | 1 623 | 2,98 | 24,00 | 1 128 | 38 952 | |
2020-05-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 47 | 47 | |||||
2020-05-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 47 | 1 576 | 3,07 | 23,93 | 1 125 | 37 714 | |
2020-04-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 50 | 50 | |||||
2020-04-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 50 | 1 529 | 3,38 | 22,82 | 1 141 | 34 892 | |
2020-04-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 24 | 24 | |||||
2020-04-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 24 | 1 479 | 1,65 | 23,47 | 563 | 34 712 | |
2020-03-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 29 | 29 | |||||
2020-03-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 29 | 1 455 | 2,03 | 19,59 | 568 | 28 503 | |
2020-03-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 22 | 22 | |||||
2020-03-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 22 | 1 426 | 1,57 | 25,15 | 553 | 35 864 | |
2020-02-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 21 | 21 | |||||
2020-02-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 21 | 1 404 | 1,52 | 26,73 | 561 | 37 529 | |
2020-02-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 23 | 23 | |||||
2020-02-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 23 | 1 383 | 1,69 | 24,82 | 571 | 34 326 | |
2020-01-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 24 | 24 | |||||
2020-01-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 24 | 1 360 | 1,80 | 23,15 | 556 | 31 484 | |
2020-01-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 20 | 20 | |||||
2020-01-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 20 | 1 336 | 1,52 | 27,58 | 552 | 36 847 | |
2019-12-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 22 | 22 | |||||
2019-12-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 22 | 1 316 | 1,70 | 24,62 | 542 | 32 400 | |
2019-12-12 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 32 173 | 32 173 | |||||
2019-12-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 19 | 19 | |||||
2019-12-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 19 | 1 294 | 1,49 | 29,22 | 555 | 37 811 | |
2019-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 19 | 19 | |||||
2019-11-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 19 | 1 275 | 1,51 | 28,14 | 535 | 35 878 | |
2019-11-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 21 | 21 | |||||
2019-11-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 21 | 1 256 | 1,70 | 27,00 | 567 | 33 912 | |
2019-10-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 22 | 22 | |||||
2019-10-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 22 | 1 235 | 1,81 | 24,23 | 533 | 29 924 | |
2019-10-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 25 | 25 | |||||
2019-10-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 25 | 1 213 | 2,10 | 22,13 | 553 | 26 844 | |
2019-09-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 23 | 23 | |||||
2019-09-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 23 | 1 188 | 1,97 | 24,11 | 555 | 28 643 | |
2019-09-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 21 | 21 | |||||
2019-09-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 21 | 1 165 | 1,84 | 26,19 | 550 | 30 511 | |
2019-08-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 19 | 19 | |||||
2019-08-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 19 | 1 144 | 1,69 | 28,42 | 540 | 32 512 | |
2019-08-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 16 | 16 | |||||
2019-08-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 16 | 1 125 | 1,44 | 34,64 | 554 | 38 970 | |
2019-07-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 18 | 18 | |||||
2019-07-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 18 | 1 109 | 1,65 | 29,89 | 538 | 33 148 | |
2019-07-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 17 | 17 | |||||
2019-07-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 17 | 1 091 | 1,58 | 31,19 | 530 | 34 028 | |
2019-06-28 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 769 231 | 14 075 269 | 5,78 | 26,00 | 20 000 006 | 365 956 994 | |
2019-06-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 26 | 26 | |||||
2019-06-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 26 | 1 074 | 2,48 | 21,25 | 552 | 22 822 | |
2019-06-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 21 350 | 13 306 038 | 0,16 | 26,89 | 574 020 | 357 748 799 | |
2019-06-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 8 137 | 13 284 688 | 0,06 | 26,95 | 219 321 | 358 068 838 | |
2019-06-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 1 905 | 13 276 551 | 0,01 | 26,20 | 49 911 | 347 844 309 | |
2019-06-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 18 608 | 13 274 646 | 0,14 | 24,95 | 464 294 | 331 219 675 | |
2019-06-10 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 20 000 | 13 256 038 | 0,15 | 26,31 | 526 220 | 348 779 616 | |
2019-06-10 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 8 688 | 13 236 038 | 0,07 | 27,95 | 242 844 | 369 969 763 | |
2019-06-10 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 41 312 | 13 227 350 | 0,31 | 27,71 | 1 144 557 | 366 466 377 | |
2019-06-10 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 6 308 | 13 186 038 | 0,05 | 27,56 | 173 835 | 363 379 517 | |
2019-06-05 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 29 484 | 13 179 730 | 0,22 | 26,11 | 769 863 | 344 138 566 | |
2019-06-05 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 9 972 | 13 150 246 | 0,08 | 25,14 | 250 678 | 330 573 514 | |
2019-06-05 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 4 236 | 13 140 274 | 0,03 | 24,99 | 105 852 | 328 357 051 | |
2019-06-05 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 34 714 | 13 136 038 | 0,26 | 24,92 | 864 920 | 327 292 268 | |
2019-06-05 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 7 427 | 13 101 324 | 0,06 | 22,86 | 169 745 | 299 432 070 | |
2019-06-05 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 7 859 | 13 093 897 | 0,06 | 22,16 | 174 159 | 290 167 304 | |
2019-06-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 30 | 30 | |||||
2019-06-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 30 | 1 048 | 2,95 | 18,27 | 548 | 19 147 | |
2019-05-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 29 | 29 | |||||
2019-05-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 29 | 1 018 | 2,93 | 18,87 | 547 | 19 210 | |
2019-05-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 33 | 33 | |||||
2019-05-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 33 | 989 | 3,45 | 16,71 | 551 | 16 526 | |
2019-04-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 26 | 26 | |||||
2019-04-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 26 | 956 | 2,80 | 21,24 | 552 | 20 305 | |
2019-04-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 29 | 29 | |||||
2019-04-02 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 29 | 930 | 3,22 | 18,79 | 545 | 17 475 | |
2019-03-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 27 | 27 | |||||
2019-03-19 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 27 | 901 | 3,09 | 20,19 | 545 | 18 191 | |
2019-03-11 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 77 137 | 13 086 038 | 0,59 | 18,94 | 1 460 674 | 247 798 524 | |
2019-03-11 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 22 863 | 13 008 901 | 0,18 | 18,10 | 413 909 | 235 511 843 | |
2019-03-11 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 20 000 | 12 986 038 | 0,15 | 17,50 | 349 910 | 227 197 228 | |
2019-03-11 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 964 | 12 966 038 | 0,01 | 17,15 | 16 535 | 222 401 263 | |
2019-03-11 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 19 036 | 12 965 074 | 0,15 | 16,56 | 315 288 | 214 736 631 | |
2019-03-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 39 | 39 | |||||
2019-03-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 39 | 874 | 4,67 | 14,01 | 546 | 12 245 | |
2019-02-20 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 39 | 39 | |||||
2019-02-20 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 39 | 835 | 4,90 | 14,04 | 548 | 11 723 | |
2019-02-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 38 | 38 | |||||
2019-02-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 38 | 796 | 5,01 | 14,08 | 535 | 11 208 | |
2019-01-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 40 | 40 | |||||
2019-01-17 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 40 | 758 | 5,57 | 13,85 | 554 | 10 498 | |
2019-01-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 45 045 | 45 045 | |||||
2019-01-03 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 45 | 718 | 6,69 | 11,97 | 539 | 8 594 | |
2018-12-31 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 3 700 | 12 946 038 | 0,03 | 14,00 | 51 792 | 181 216 051 | |
2018-12-31 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 942 338 | 0,08 | 13,99 | 139 866 | 181 019 305 | |
2018-12-31 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 932 338 | 0,08 | 13,51 | 135 070 | 174 677 089 | |
2018-12-31 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 922 338 | 0,08 | 13,42 | 134 201 | 173 419 068 | |
2018-12-31 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 912 338 | 0,08 | 13,35 | 133 469 | 172 339 684 | |
2018-12-31 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 902 338 | 0,08 | 12,04 | 120 394 | 155 336 408 | |
2018-12-31 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 892 338 | 0,08 | 12,03 | 120 315 | 155 114 165 | |
2018-12-26 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 882 338 | 0,08 | 12,09 | 120 937 | 155 795 131 | |
2018-12-26 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 872 338 | 0,08 | 12,34 | 123 384 | 158 824 055 | |
2018-12-26 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 862 338 | 0,08 | 12,40 | 123 966 | 159 449 259 | |
2018-12-26 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 6 500 | 12 852 338 | 0,05 | 13,78 | 89 569 | 177 103 932 | |
2018-12-26 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 3 500 | 12 845 838 | 0,03 | 12,44 | 43 527 | 159 755 980 | |
2018-12-26 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 842 338 | 0,08 | 12,27 | 122 731 | 157 615 299 | |
2018-12-26 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 832 338 | 0,08 | 13,17 | 131 742 | 169 055 787 | |
2018-12-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 42 | 42 | |||||
2018-12-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 42 | 673 | 6,66 | 12,85 | 540 | 8 648 | |
2018-12-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 822 338 | 0,08 | 14,13 | 141 327 | 181 214 256 | |
2018-12-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 1 704 | 12 812 338 | 0,01 | 15,18 | 25 862 | 194 452 854 | |
2018-12-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 8 296 | 12 810 634 | 0,06 | 14,85 | 123 230 | 190 291 720 | |
2018-12-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 450 | 12 802 338 | 0,00 | 15,20 | 6 840 | 194 595 538 | |
2018-12-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 9 550 | 12 801 888 | 0,07 | 14,51 | 138 542 | 185 716 989 | |
2018-12-18 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 792 338 | 0,08 | 15,08 | 150 838 | 192 957 068 | |
2018-12-13 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 782 338 | 0,08 | 15,77 | 157 728 | 201 613 261 | |
2018-12-13 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 4 550 | 12 772 338 | 0,04 | 15,65 | 71 218 | 199 915 189 | |
2018-12-13 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 5 450 | 12 767 788 | 0,04 | 15,25 | 83 128 | 194 744 517 | |
2018-12-10 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 9 500 | 12 762 338 | 0,07 | 14,98 | 142 291 | 191 154 299 | |
2018-12-10 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 500 | 12 752 838 | 0,00 | 14,66 | 7 330 | 186 954 055 | |
2018-12-10 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
P - Purchase | 10 000 | 12 752 338 | 0,08 | 14,62 | 146 243 | 186 494 017 | |
2018-12-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 40 | 40 | |||||
2018-12-04 |
|
4 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
A - Award | 40 | 631 | 6,77 | 13,40 | 536 | 8 455 | |
2018-11-29 | 3 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
12 743 520 | ||||||||
2018-11-29 | 3 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
25 485 267 | ||||||||
2018-11-29 | 3 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
12 743 520 | ||||||||
2018-11-29 | 3 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
25 485 267 | ||||||||
2018-11-29 | 3 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
12 743 520 | ||||||||
2018-11-29 | 3 | ODT |
Odonate Therapeutics, Inc.
Common Stock |
25 485 267 |